Zimmer Biomet Holdings, Inc ZBH

NYSE US Health Care

$91.34 ▼ -0.31% ($-0.28)

Index member: S&P 500

Open $90.96

Prev Close $91.62

Day Range $90.60 – $91.59

52W Range $79.12 – $106.88

Market Cap $18.37B

P/E (TTM) 21.80

Beta 0.51

Div Yield 1.04%

EPS (TTM) $4.11

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2001-07-25
Shares Out.	193,460,000
Website	zimmerbiomet.com/en ↗
Phone	15742676131
Employees	17,000
Revenue	$2.18B
Gross Profit	$1.54B
Net Income	$199.6M
Free Cash Flow	$1.06B
Total Assets	$22.80B
Total Liabilities	$10.17B
Equity	$12.63B

About Zimmer Biomet Holdings, Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Zimmer Biomet Holdings, Inc is a publicly traded company under the ticker symbol ZBH on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.